MIR100HG is expressed at high levels in triple-negative breast cancer (Chen et al., 2020b), laryngeal squamous cell carcinoma (Huang et al., 2019), gastric cancer (Li et al., 2019b) and colorectal cancer (Li et al., 2019a). The gene discussed is MIR100HG; the disease is colorectal cancer.